'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers
Clinical trial NCT05113264 · COMPLETED
Trial details
- NCT number
- NCT05113264
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2024-11-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.